Screening for G6PD Mediterranean mutation among Egyptian neonates with high or prolonged jaundice

HAEMA

Volumn 9, Issue 1, 2006, Pages 81-88

  Settin, Ahmad ^a   Al Haggar, Mohammad ^a,c   Al Baz, Rizk ^b   Yousof, Hisham ^b   Osman, Nayera ^b  

^a MANSOURA UNIVERSITY   (Egypt)

^b MANSOURA UNIVERSITY CHILDREN S HOSPITAL   (Egypt)

^c NONE   (Saudi Arabia)

Author keywords

G6PD deficiency; Mediterranean mutation; Neonatal screening

Indexed keywords

BILIRUBIN; C REACTIVE PROTEIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HEMOGLOBIN; NUCLEOTIDE;

AGAR GEL ELECTROPHORESIS; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BASE PAIRING; CONTROLLED STUDY; DNA EXTRACTION; EGYPT; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; GREECE; HUMAN; INFANT; IRAN; JAMAICA; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN JAUNDICE; POLYMERASE CHAIN REACTION; PREVALENCE; SCREENING; TURKEY (REPUBLIC);

EID: 33646483042     PISSN: 11082682     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Alving AS, Carson PE, Flanagan CL, Ickes CE. Enzymatic deficiency in primaquine-sensitive erythrocytes. Science 1956; 124: 484-485.
2. Chan TK, Todd D, Wong CC. Tissue enzyme levels in erythrocyte G6PD deficiency. J Lab Clin Med 1965; 66: 937-942.
3. Dausset J, Contu L. Drug-induced hemolysis. Annu Rev Med 1967; 18: 55-70.
4. Beutler E. Drug-induced hemolytic anemia. Pharmacol Rev 1969; 21: 73-103.
5. Fairbanks VF, Fernandez MN. The identification of metabolic errors associated with hemolytic anemia. JAMA 1969; 208: 316-320.
6. Chan TK, Chesterman CJ, McFadzean AJS, Todd D. The survival of G6PD deficient erythrocytes in patients with typhoid fever on chloramphenicol therapy. J Lab Clin Med 1971; 77: 177-184.
7. Chan TK, Todd D, Tso SC. Drug-induced haemolysis in glucose-6-phosphate dehydrogenase deficiency. BMJ 1976; 2: 1227-1229.
8. Chan TK, Todd D. Haemolysis complicating viral hepatitis in patients with G6PD deficiency. BMJ 1975; 1: 131-133.
9. Chang JG, Chiou SS, Perng LI et al. Molecular characterization of G6PD deficiency by natural and amplification created restriction sites: five mutation accounts for most G6PD deficiency cases in Taiwan. Blood 1992; 80: 1079-1082.
10. Valaes T. Severe neonatal jaundice associated with glucose-6-phosphate dehydrogenase deficiency: Pathogenesis and global epidemiology. Acta Paediatr 1994; 394(suppl.): 58-76.
11. Kaplan M, Vreman HJ, Hammerman C, Schimmel MS, Abrahamov A, Stevenson DK. Favism by proxy in nursing glucose-6-phosphate dehydrogenase-deficient neonates. J Perinatol 1998; 18(6 Pt 1): 477-479.
12. Valaes T, Karaklis A, Stravrakakis D, Bavela-Stravrakakis K, Perakis A, Doxiadis SA. Incidence and mechanism of neonatal jaundice related to glucose-6-phosphate dehydrogenase deficiency. Pediatr Res 1969; 3: 448-458.
13. Kaplan M, Beutler E, Vreman HJ et al. Neonatal hyperbilirubinemia in glucose-6-phosphate dehydrogenase deficient heterozygotes. Pediatrics 1999; 104: 68-74.
14. Beutler E. Glucose-6-phosphate dehydrogenase deficiency. Blood 1994; 84: 3613-3636.
15. Zinkham WH, Oski FA. Henna: a potential cause of oxidative hemolysis and neonatal hyperbilirubinemia. Pediatrics 1996; 97: 707-709.
16. Olowe SA, Ransome-Kuti O. The risk of jaundice in G6PD deficient babies exposed to menthol. Acta Paediatr Scand 1980; 69: 341-345.
17. WHO Working Group: Glucose-6-phosphate dehydrogenase deficiency. Bullet WHO 1989; 67: 601-611.
18. Doxiadis SA, Fessas PH, Valaes T, Mastrokalos N. Glucose-6-phosphate dehydrogenase deficiency: a new aetiological factor of severe neonatal jaundice. Lancet. 1961; 1: 297-301.
19. Missiou-Tsagaraki S. Screening for glucose-6-phosphate dehydrogenase deficiency as a preventive measure: prevalence among 1.286.000 Greek new born infants. J Pediatr 1991; 119: 293-299.
20. Hafez M, Settin A, El-Morsy Z et al. Gene Mutations of Glucose-6-phosphate dehydrogenase in Egypt. Egyptian J Pediatr 2000; 17: 651-671.
21. Hassan S, Aziz M, Abd El-Ghany H et al. Frequency of the 563 C-T Mediterranean mutation among a group of Egyptian pediatric patients. Lab Hemat 2000; 6: 127-131.
22. Beutler E, Kuhl W, Vives-Corrons JL, Prchal JT. Molecular heterogeneity of glucose-6-phosphate dehydrogenase A. Blood 1989; 47: 2550-2555.
23. Kurdi-Haidar B, Mason PJ, Berrebi A et al. Origin and Spread of the glucose-6-phosphate dehydrogenase variant (G6PD-Mediterranean) in the Middle East. Am J Hum Genet 1990; 47: 1013-1019.
24. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. A laboratory manual, 2nd edition, Cold Spring Harbor Laboratory Press, 1989, pp. 286.
25. Smith DR. Agarose gel electrophesis (p17) and Restriction endonuclease digestion of DNA. In Methods in molecular biology [Basic DNA and RNA protocols], Harwood, Ajed, vol. 58, Humana Press, Totowa. New Jersey, 1996, pp. 11-17.
26. SPSS. Statistical Package for Social Science, standard version 10.0.1; SPSS Inc., Chicago, IL, 1999.
27. Hosini W, Shebl S, Abd El-Latif E. Study of the prevalence of glucose-6-phosphate dehydrogenase enzyme deficiencies in unexplained neonatal jaundice. MD Thesis, Tanta University, Egypt, 1996.
28. Shebl S SH. The common problems among the Egyptian newborn. Neonatal Scientific Conference; Jan (6-10), 1992, pp.1-17.
29. Hammad SE, Badr El-Din AA, Abdel-Aal AA and El-Kenany HA. The erythrocyte enzyme G6PD deficiency and its relation to neonatal jaundice. MD Thesis, Alexandria University, Egypt, 1986.
30. Oner R, Gumruk F, Acar C, Oner C, Gurgey A, Altay C. Molecular characterization of Glucose-6-phosphate dehydrogenase deficiency in Turkey. Haematologica 2000; 85: 320-321.
31. Casado A, Casado C, Lopez-Fernandez E, de la Torre R. Enzyme deficiencies in neonates with jaundice. Panminerva Med 1995; 37: 175-177.
32. Tzoneva M, Bulanov N, Maviudieva D, Lalchev S, Toncheva D, Tanev D. Frequency of glucose-6-phosphate dehydrogenase deficiency in relation to altitude on malaria hypothesis. Bull World Health Organ 1980; 58: 659-662.
33. Al-Omran A, Al-Ghazal F, Gupta S, Thomas BJ. Glucose-6-phosphate dehydrogenase deficiency and Neonatal jaundice in Al-Hofuf area. Ann Saudi Med 1999; 19: 130-135.
34. Iranpour R, Akbar MR, Haghshenas I. Glucose-6-phosphate dehydrogenase deficiency in neonates. Indian J Pediatr 2003; 70: 855-857.
35. Rehman H, Khan MA, Hameed A, Roghani MT, Ahmad A. Erythrocyte Glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice. J Pak Med Assoc 1995; 45: 259-260.
36. Nuchprayoon I, Sanpavat S, Nuchprayoon S. Glucose-6-phosphate dehydrogenase (G6PD) mutations in Thailand: G6PD Viangchan (871G.A) is the most common deficiency variant in the Thai population. Hum Mutat 2002; 19: 185.
37. Gibbs WN, Gray R, Lowry M. Glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice in Jamaica. Br J Haematol 1979; 43: 263-274.
38. Mohareb S, El-Tahan H, El-Sallab S, Sayed M, El-Tonbary Y. Some aspects of G6PD deficiency anemia in the North East Delta. J Egypt Pediatr Assoc 1982; 1: 34-38.
39. McCaffrey R, Awny Y. Glucose-6-phosphate dehydrogenase deficiency in Egypt: with a reference on the methemoglobin reduction test. Blood 1970; 36: 793-797.
40. Nasserullah Z, Alshammari A, AlAbbas M et al. Regional experience with newborn screening for sickle cell disease, other hemoglobinopathies and G6PD deficiency. Ann Saudi Med 2003; 23: 354-357.
41. Abdulrazzaq YM, Micallef R, Qureshi M et al. Diversity in expression of glucose-6-phosphate dehydrogenase deficiency in females. Clin Genet 1999; 55: 13-19.
42. Al-Rayami A, Ebrahim GJ. Genetic blood disorders survey in sultanate of Oman. J Trop Pediatr 2003; 49: 1-20.
43. Usanga EA, Ameen R. Glucose-6-phosphate dehydrogenase deficiency in Kuwait, Syria, Egypt, Iran, Jordan and Lebanon. Hum Hered 2000; 50: 158-161.
44. Drousiotou A, Touma EH, Andreo N et al. Molecular characterization of G6PD deficiency in Cyprus. Blood cells Mol Dis 2004; 33: 25-30.
45. Smith MB. The incidence of G6PD deficiency in a population of Greek, Italian and Yugoslav origin in Australia. Med J Aust 1976; 25: 485-486.
46. Cladera Serra A, Oliva Berini E, Torrent Quetglas M, Bartolozzi Castilla E. Prevalence of glucose-6-phosphate dehydrogenase deficiency in a student population on the island of menorca. Sangre (Barc) 1997; 42: 363-367.
47. Keskin N, Ozdes I, Keskin A, Acikbas I, Bagci H. Incidence and molecular analysis of G6PD deficiency in the province of Denizli, Turkey. Med Sci Monit 2002; 8: CR453-CR456.
48. Shusheela K, Grimes A, Scopes JW. Prevalence of glucose-6-phosphate dehydrogenase deficiency. Arch Dis Child 1985; 60: 184.
49. Jain R. Abnormal hemoglobins, thalassemia and G6PD deficiency in Libya. Br J Haematol 1983; 54: 154-155
50. Chiang SH, Wu SJ, Wu KF, Hsiao KJ. Neonatal screening for G6PD deficiency in Taiwan. Southeast Asian J Trop Med Public Health 1999; 30(suppl. 2): 72-74.
51. Lim HH, Daniel LM, Lee J, Tan MC. Predicting significant Hyperbilirubinemia and early discharge for G6PD deficient newborns. Ann Acad Med Singapore 2003; 32: 257-261.
52. Ardatia KO, Bajakian KM, Tabbara KS. Effect of Glucose-6-phosphate dehydrogenase deficiency on neutrophil function. Acta Hematol 1997; 97: 211-215.
53. Luzzatto L. Glucose-6-phosphate dehydrogenase deficiency. In Brown MJ (ed): Advanced Medicine, London, Churchill Livingstone, 1986; pp. 398-403.
54. Stiene-Martine EA, Lotspeich-Steininger CA, Koepke JA. Glucose-6-phosphate dehydrogenase deficiency. In Clinical Hematology Principles, Procedure Correlations 2nd edition, 1998, pp. 261-267.
55. Kaplan M, Leiter C, Hammerman C, Rudensky B. Comparison of commercial screening tests for glucose-6-phosphate dehydrogenase deficiency in the neonatal period. Clin Chem 1997; 13: 1236-1237.
56. Eckman BA, Aaronson JS, Borkowski JA et al. The Merck Gene Index browser: an extensible data integration system for gene finding, gene characterization and EST data mining. Bioinformatics 1998; 14: 2-13.
57. Wilson SH, Sobol RW, Beard WA, Horton JK, Prasad R, Vande Berg BJ. DNA polymerase beta and mammalian base excision repair. Cold Spring Harb Symp Quant Biol 2000; 65: 143-155.
58. Ratrisawadi V, Horpaopan S, Chotigeat U et al. Neonatal screening program in Rajavithi Hospital, Thailand. Southeast Asian J Trop Med Public Health 1999; 30(suppl.2): 28-32.
59. Beutler E. Glucose-6-phosphate dehydrogenase: A new prospective. Blood 1989; 73: 1397-1401.
60. Rovira A, Vulliamy T, Pujades MA, Luzzatto L, Corrons JL. Molecular genetics of Glucose-6-phosphate dehydrogenase (G6PD) deficiency in Spain: identification of two new point mutations in the (G6PD) gene. Br J Haematol 1995; 91: 66-71.
61. Soemantri AG, Saha S, Saha N, Tay JS. Molecular variants of red cell glucose-6-phosphate dehydrogenase deficiency in central Java, Indonesia. Hum Hered 1995; 45: 346-350.
62. Kaeda JS, Chhotray GP, Ranjit MR et al. A new glucose-6-phosphate dehydrogenase variant, G6PD Orissa (44 Ala - Gly), is the major polymorphic variant in tribal populations in India. Am J Hum Genet 1995; 57: 1335-1341.
63. Kaplan M, Hammerman C. Glucose-6-phosphate dehydrogenase deficiency: a hidden risk for kernicterus. Semin Perinatol 2004; 28: 356-364.
64. Ainoon O, Yu YH, Amir Muhriz AL, Boo NY, Cheong SK, Hamidah NH. Glucose-6-phosphate dehydrogenase (G6PD) variants in Malaysian Malays. Hum Mutat 2003; 21: 101.
65. Ainoon O, Joyce J, Boo NY, Cheong SK, Zainal ZA, Hamidah NH. Glucose-6-phosphate dehydrogenase (G6PD) variants in Malaysian Chinese. Hum Mutat 1999; 14: 352.